During the past decade, Colin Bayliss Research and Teaching Unit conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Colin Bayliss Research and Teaching Unit" are "Osteoarthritis of the Knee" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Colin Bayliss Research and Teaching Unit" in a lesser frequency.

Most popular intervention types in "Colin Bayliss Research and Teaching Unit" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast 30 mg" (1 trials), "DSP" (1 trials), "Normal Saline" (1 trials), "Placebo" (1 trials) and "TLC599" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colin Bayliss Research and Teaching Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Colin Bayliss Research and Teaching Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Colin Bayliss Research and Teaching Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Colin Bayliss Research and Teaching Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".